EFFECTS OF RECOMBINANT INSULIN-LIKE GROWTH FACTOR-I ON INSULIN-SECRETION AND RENAL-FUNCTION IN NORMAL HUMAN-SUBJECTS
EFFECTS OF RECOMBINANT INSULIN-LIKE GROWTH FACTOR-I ON INSULIN-SECRETION AND RENAL-FUNCTION IN NORMAL HUMAN-SUBJECTS
复制标题
DOI:
10.1073/pnas.86.8.2868
复制
发表时间:
1989-04-01
影响因子:
11.1
通讯作者:
FROESCH, ER
中科院分区:
文献类型:
--
作者:
GULER, HP;SCHMID, C;FROESCH, ER
Insulin-like growth factor I (IGF-I) is an important mediator of growth hormone (GH) action and it appeared tempting to evaluate possible clinical applications. Recombinant IGF-I was infused s.c. at a dose of 20 .mu.g/kg of body weight per hour during 6 days in two healthy adult subjects. Blood glucose and fasting insulin levels remained within normal limits and IGF-II levels were suppressed. In contrast to insulin, fasting C peptide levels were decreased. GH secretion was also suppressed by IGF-I. Our preliminary data allow us to distinguish between the effects of GH per se and those of IGF-I: GH causes hyperinsulinism, whereas IGF-I leads to decreased insulin secretion. Glomerular filtration rate, as estimated by creatinine clearance, increased to 130% of preinfusion values during the IGF-I infusion. Total creatinine and urea excretion remained unchanged. We conclude that IGF-I influences kidney function and, in contrast to GH, exerts an insulin-sparing effect. It may be speculated that the therapeutic spectrum of IGF-I is quite different from that of GH.